PTGS2 and colonic neoplasm: Flavonoids could affect cancer risk through anti-inflammatory and anti-tumor activities, mainly by inhibiting cycloxygenase-2 (COX2) in colon cancer cells, which is associated with a reduced risk of CRC [35].